Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system and regenerate tissue.

Critics say the misleading term actually refers to a heterogeneous population of cells, including possible tissue-specific progenitor cells and nonstem cells all lumped together.

The Scientist looks at one such Houston-based purveyor that has been treating patients abroad for years with mesenchymal stem cells.

Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 

Adding or removing water changes how stem cells differentiate.

The technique, demonstrated in mice using engineered mesenchymal stem cells, has potential for both diagnosis and treatment.

These engineered “cells” were made from the secretions and membranes of human mesenchymal stem cells.

See researchers' recipe for synthetic mesenchymal stem cells, which showed cardiac regenerative potential in mice.

Paolo Bianco crusaded against cell therapy fraud and hype.